Comparing effectiveness of two antibodies (Aducanumab and Gantenerumab) on reducing amyloid-beta plaques

Nikhila Paleati; Akhil Godbole; Pranav Neravetla; Emily Schmitt Lavin; Arthur Sikora

doi:10.1016/j.jbc.2023.103497

Comparing effectiveness of two antibodies (Aducanumab and Gantenerumab) on reducing amyloid-beta plaques

Nikhila Paleati
, Akhil Godbole
, Pranav Neravetla
, Emily Schmitt Lavin
, Arthur Sikora

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	103497
Pages (from-to)	S245-S246
Number of pages	2
Journal	Journal of Biological Chemistry
Volume	299
Issue number	3
DOIs	https://doi.org/10.1016/j.jbc.2023.103497
State	Published - 2023

Access to Document

10.1016/j.jbc.2023.103497License: CC BY

Cite this

@article{fed32abb41d54c88ae691c1b8b17ec24,

title = "Comparing effectiveness of two antibodies (Aducanumab and Gantenerumab) on reducing amyloid-beta plaques",

author = "Nikhila Paleati and Akhil Godbole and Pranav Neravetla and Lavin, \{Emily Schmitt\} and Arthur Sikora",

year = "2023",

doi = "10.1016/j.jbc.2023.103497",

language = "English",

volume = "299",

pages = "S245--S246",

journal = "Journal of Biological Chemistry",

issn = "0021-9258",

publisher = "American Society for Biochemistry and Molecular Biology Inc.",

number = "3",

}

TY - JOUR

T1 - Comparing effectiveness of two antibodies (Aducanumab and Gantenerumab) on reducing amyloid-beta plaques

AU - Paleati, Nikhila

AU - Godbole, Akhil

AU - Neravetla, Pranav

AU - Lavin, Emily Schmitt

AU - Sikora, Arthur

PY - 2023

Y1 - 2023

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=novaseuniv&SrcAuth=WosAPI&KeyUT=WOS:001040892100423&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/j.jbc.2023.103497

DO - 10.1016/j.jbc.2023.103497

M3 - Meeting abstract

SN - 0021-9258

VL - 299

SP - S245-S246

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

IS - 3

M1 - 103497

ER -

Comparing effectiveness of two antibodies (Aducanumab and Gantenerumab) on reducing amyloid-beta plaques

Access to Document

Other files and links

Cite this